|
Volumn 34, Issue 6, 2002, Pages 2379-2381
|
The ATG bolus does not induce a persistent inversion of the CD4/8 ratio
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN M;
LYMPHOCYTE ANTIBODY;
OKT 3;
ADULT;
CELL COUNT;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INFUSION;
FEMALE;
HUMAN;
INCIDENCE;
INFECTION RISK;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SEROCONVERSION;
T LYMPHOCYTE;
ADULT;
ANTILYMPHOCYTE SERUM;
AZATHIOPRINE;
CD4-CD8 RATIO;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
FLOW CYTOMETRY;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE SUBSETS;
MALE;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 0036756407
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03279-7 Document Type: Conference Paper |
Times cited : (4)
|
References (15)
|